Indications
Repair of symptomatic, localised, full-thickness cartilage defects of the knee joint grade III or IV
Composition
- International name (INN)
- autologous cartilage-derived articular chondrocytes, in-vitro expanded
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Jelrix
- ATC code
- M09AX02
- Therapeutic area
- Knee Injuries, Cartilage Diseases, Knee Joint
- Marketing authorisation holder
- TETEC Tissue Engineering Technologies AG
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/004594